The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 127.80
Bid: 127.60
Ask: 127.80
Change: 0.00 (0.00%)
Spread: 0.20 (0.157%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 127.80
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Jan 2018 07:02

RNS Number : 9441B
NCC Group PLC
16 January 2018
 

 

NCC Group plc

 

Directorate change

 

16th January 2018

 

NCC Group plc (LSE: NCC or the "Company"), the independent global cyber security and risk mitigation expert, announces that in line with best practice, after nine years' tenure, Debbie Hewitt MBE, Senior Independent Director, will resign and step down from the Board on 28 March 2018. Chris Batterham, Non-Executive Director will become Senior Independent Director and Jonathan Brooks, Non-Executive Director will become Chairman of the Remuneration Committee.

In addition, as part of the broader Board succession planning, after six years' tenure, Thomas Chambers, Non-Executive Director, will relinquish the Chair of Audit role with effect from April 2018 and will resign and step down from the Board, following the Company's AGM on 19th September 2018. Chris Batterham, Non-Executive Director will become Chairman of the Audit Committee from 1st April 2018.

The Board is in the process of recruiting an additional Non-Executive Director and an announcement will be made in due course.

Now that his role has reverted to Non-Executive Chairman, Chris Stone will become Chairman of the Nominations Committee and of the Cyber Security Committee.

Chris Stone, Chairman, said;

"We would like to thank Debbie for her valuable contribution to the business over the last nine years, for her commitment and for her contribution to the appointment of four new Directors to the Board over the last 12 months.

Similarly, we thank Thomas for his valuable contribution over the last six years, for his diligent approach and for his leadership of the Audit Committee.

The Board is appreciative of the role that they have both played and wish them well for the future."

 

Enquiries:

NCC Group

Chris Stone, Executive Chairman

0161 209 5200

Maitland

Neil Bennett

Al Loehnis

 

0207 379 5151

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUVVKRWRAAAAR
Date   Source Headline
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review
20th Jul 20234:51 pmRNSHolding(s) in Company
19th Jul 20234:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.